Skip to main content
. 2022 Apr;23(4):1415–1423. doi: 10.31557/APJCP.2022.23.4.1415

Table 2.

Number of Cases, 5-Year Overall Survival Rate of EOC Patients, and p-values of log-rank Tests

Variable No. of cases, n (%) 5-SR (95% CI) p-valuea
Age at diagnosis (years) <0.001*
< 40 57 (27.5) 92.6 (81.3-97.2)
40–49 46 (22.2) 66.6 (49.7-79.0)
50–59 60 (29.0) 40.4 (26.7-53.6)
60–69 25 (12.1) 43.9 (19.3-66.2)
≥70 19 (9.2) 40.5 (18.7-61.5)
District 0.229
Brunei Muara 135 (68.2) 57.8 (48.4-66.1)
Tutong 32 (16.2) 60.6 (39.2-76.5)
Belait 27 (13.6) 76.2 (54.1-88.6)
Temburong 4 (2.0) 100
Ethnicity 0.241
Malay 173 (83.6) 58.9 (50.7-66.3)
Chinese 22 (10.6) 81.8 (58.5-92.8)
Others 12 (5.8) 64.8 (25.3-87.2)
Stage <0.001*
Localized 74 (38.9) 94.1 (85.0-97.8)
Regional 52 (27.4) 46.4 (31.7-59.8)
Distant 64 (33.7) 38.0 (25.2-50.7)
Histology <0.001*
Serous carcinoma 58 (28.0) 62.3 (48.1-73.7)
Mucinous carcinoma 64 (30.9) 78.5 (64.9-87.3)
Endometrioid carcinoma 22 (10.6) 55.8 (27.4-76.9)
Clear cell carcinoma 11 (5.3) 68.2 (28.6-88.9)
Undifferentiated or other-epithelial 52 (25.1) 39.6 (25.7-53.2)

5-SR, 5-year overall survival rate; CI, confidence interval; ap-value for Log Rank Test; *, statistically significant (p<0.05)